Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Threshold Pharma's TH-302 for pancreatic cancer shows positive Phase 2b results
Yahoo/Fly on the Wall
Tuesday, February 21, 2012 - 9:02am
tags:
Threshold Pharmaceuticals, pancreatic cancer, TH-302
Friday's Overreaction Provides Great Entry Point For Gilead
Seeking Alpha
Tuesday, February 21, 2012 - 9:01am
tags:
Gilead, Vertex, hepatitis C, Pharmasset, PSI-7977
US FDA staff focus on safety of Forest lung drug
Reuters
Tuesday, February 21, 2012 - 9:00am
tags:
FDA, Forest Labs, COPD, aclidinium bromide, Almirall
The Case for Shorting Elan Into Upcoming Alzheimer's Trial Results
TheStreet.com
Tuesday, February 21, 2012 - 8:59am
tags:
Elan, Alzheimer's disease, bapineuzumab, monoclonal antibodies
Pfizer eyes tie-ups with more Chinese drugmakers
Reuters
Tuesday, February 21, 2012 - 8:58am
tags:
Pfizer, China, Zhejiang Hisun
After Gilead's Drop: Hedging 5 Biotechnology Stocks
Seeking Alpha
Monday, February 20, 2012 - 1:44pm
tags:
Gilead, Acorda, Amylin, Celgene, United Therapeutics
Amyris Finds Scaling Up More Difficult Than Expected
Seeking Alpha
Monday, February 20, 2012 - 12:28pm
tags:
Amyris
What's Next For Amarin's Lucky Investors?
Seeking Alpha
Monday, February 20, 2012 - 12:27pm
tags:
Amarin, GSK
China Biotech In Review: GSK To Explore Synthetic Versions Of Chinese Medicines
Seeking Alpha
Monday, February 20, 2012 - 12:24pm
tags:
GSK, China, Tianyin Pharmaceutical, Beijing Leadman Biochemistry
Biotie Being Courted by Potential Partners for Alzheimer’s Drug
Bloomberg
Monday, February 20, 2012 - 12:22pm
tags:
BioTie Therapies, Alzheimer's disease, SYN120, Roche
Pfizer plans to float animal healthcare business-FT
Reuters
Monday, February 20, 2012 - 12:21pm
tags:
Pfizer, animal health
5 Overlooked Healthcare Stocks To Consider Now
Seeking Alpha
Sunday, February 19, 2012 - 11:24am
tags:
Exelixis, Momenta, Neurocrine Biosciences, Thoratec, Syneron Medical
Par Pharmaceutical Completes Acquisition of Edict Pharmaceuticals
Bradenton Herald, FL
Sunday, February 19, 2012 - 11:20am
tags:
Par Pharmaceutical, Edict Pharmaceuticals
Avedro Raises Additional Series C and Debt Funding
TechFinance
Sunday, February 19, 2012 - 11:19am
tags:
Avedro
How Does Big Pharma Boost Its Returns?
Motley Fool
Sunday, February 19, 2012 - 11:16am
tags:
Novartis, GSK, Merck
Taking Advantage Of Johnson & Johnson's Unstickiness
Seeking Alpha
Sunday, February 19, 2012 - 11:10am
tags:
JNJ
An Analysis Of 5 Major Drug Makers
Seeking Alpha
Sunday, February 19, 2012 - 11:08am
tags:
Merck, Abbott Laboratories, JNJ, Bristol-Myers Squibb, Eli Lilly
Mylan Resolves Defamation Litigation Against Pittsburgh Post-Gazette and Two of Its Reporters
Bradenton Herald, FL
Saturday, February 18, 2012 - 1:22pm
tags:
Mylan
Pfizer And Hisun Announce Progress On Potential Joint Venture To Increase Access To High Quality Branded Generic Medicines
PharmiWeb
Saturday, February 18, 2012 - 12:47pm
tags:
Pfizer, Zhejiang Hisun, generics
1 Biotech Punished by Hep-C Overreaction
Motley Fool
Saturday, February 18, 2012 - 12:40pm
tags:
Gilead Sciences, hepatitis C, GS-7977

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.